← Open Payments lookup

LINDA CALLAGHAN: Open Payments

NPI 1477768786 · WASHINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$365 in 18 payments from 8 companies in 2025. Trend: 2023 $780 · 2024 $885 · 2025 $365

Food & beverage: $358Education: $7
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.6$155
Otsuka America Pharmaceutical, Inc.3$54
Alkermes, Inc.3$52
E.R. Squibb & Sons, L.L.C.2$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20
Axsome Therapeutics, Inc.1$19
Takeda Pharmaceuticals U.S.A., Inc.1$18
ABBVIE INC.1$14

Products named: FANAPT, REXULTI, ARISTADA, COBENFY, CAPLYTA, Auvelity, TRINTELLIX, VRAYLAR.

Industry payments across IN — which companies pay providers there.